Research highlights presented at the virtual NFID 2021 Annual Conference on Vaccinology Research:
COVID-19 mRNA Vaccines and Pregnancy
Oral Abstract Presentation: Moro P, Olson C, Marquez P. Safety of Pfizer-BioNTech and Moderna COVID-19 vaccines in pregnancy in the vaccine adverse event reporting system, December 14, 2020–March 26, 2021.
Racial Differences in COVID-19 Vaccination Acceptance
Oral Abstract Presentation: Wagner A, Wileden L, Shanks T, et al. Mediators of racial differences in COVID-19 vaccination intent in Detroit, MI.
School-Required Immunizations and the COVID-19 Vaccines
Oral Abstract Presentation: Beatty S, Villwock J. Attitudes of suburban, Kansas parents regarding school-required immunization of the coronavirus pandemic.
Using an mRNA Vaccine to Prevent CMV Infection
Oral Abstract Presentation: Panther L, Fierro C, Brune D, et al. Safety and immunogenicity of messenger RNA (mRNA) vaccine against cytomegalovirus (CMV) infection: Phase 2 Interim Data.
Hepatitis B Virus Vaccination and Enhancing Immunogenicity
Oral Abstract Presentation: Diaz-Mitoma F, Vesikari T, Langley J, et al. Higher seroprotection rates (SPR) and anti-HBs titers achieved in adults with a 3-antigen hepatitis B vaccine (3A-HBV) compared to a 1-antigen hepatitis B vaccine (1A-HBV): results of the PROTECT study.
Concomitant Receipt of Recombinant Zoster Vaccine With Another Vaccine
Oral Abstract Presentation: Bruxvoort K, Qian L, Wu J, Ackerson B, Sy L, Florea A, Tseng HF. Herpes zoster following recombinant zoster vaccine with or without concomitant vaccine.
Durable Protection by a Single-Dose Universal Influenza Vaccine
Oral Abstract Presentation: Lo CY, Misplon J, Li X, Price G, Ye Z, Epstein S. Durable protection by a single-dose universal influenza vaccine.
For information about NFID complimentary webinars, visit www.nfid.org/webinars